A_DT
microtitre_NN
assay_NN
system_NN
for_IN
glucocorticoid_NN
receptors_NNS
:_:
decreased_VBN
receptor_NN
concentration_NN
in_IN
myocardial_JJ
infarction_NN
._.

A_DT
major_JJ
difficulty_NN
in_IN
determination_NN
of_IN
glucocorticoid_NN
receptor_NN
sites_NNS
is_VBZ
the_DT
very_RB
complicated_JJ
assay_NN
procedure_NN
._.

Therefore_RB
,_,
we_PRP
describe_VBP
a_DT
microtitre_NN
assay_NN
system_NN
for_IN
glucocorticoid_NN
receptors_NNS
which_WDT
is_VBZ
a_DT
whole-cell_JJ
competitive_JJ
binding_NN
radioassay_NN
using_VBG
-LCB-_-LRB-
3H-RCB_JJ
--_JJ
dexamethasone_NN
as_IN
radioligand_NN
._.

This_DT
modification_NN
of_IN
a_DT
previously_RB
described_VBN
protocol_NN
simplifies_VBZ
and_CC
reduces_VBZ
laboratory_NN
work_NN
and_CC
allows_VBZ
assay_NN
reproducibility_NN
to_TO
be_VB
controlled_VBN
more_RBR
reliably_RB
._.

Thus_RB
enabled_VBN
to_TO
perform_VB
the_DT
test_NN
on_IN
multiple_JJ
blood_NN
samples_NNS
in_IN
parallel_NN
,_,
we_PRP
investigated_VBD
cardiac_JJ
infarction_NN
patients_NNS
over_IN
a_DT
12-day_JJ
period_NN
to_TO
test_VB
if_IN
glucocorticoid_NN
receptor_NN
binding_NN
is_VBZ
altered_VBN
in_IN
this_DT
'_``
stressful_JJ
'_''
disease_NN
._.

On_IN
the_DT
first_JJ
day_NN
of_IN
the_DT
disease_NN
,_,
glucocorticoid_NN
receptor_NN
capacity_NN
was_VBD
significantly_RB
decreased_VBN
without_IN
alteration_NN
of_IN
the_DT
receptor-ligand_JJ
affinity_NN
,_,
whereas_IN
on_IN
days_NNS
4_CD
and_CC
12_CD
the_DT
number_NN
of_IN
receptor_NN
sites_NNS
was_VBD
normal_JJ
again_RB
._.

This_DT
result_NN
fits_VBZ
well_RB
into_IN
the_DT
general_JJ
observation_NN
of_IN
stress-induced_JJ
down-regulation_NN
of_IN
immune_JJ
responses_NNS
._.

